Clinical trial

A Study to Explore the PK and PD of INV-202 in Metabolic Syndrome

NCT05282446

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-03-01

PhasePHASE1

Study timeline

Study start (actual)2022-03-01Date precision: day

Registry last updated2025-03-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metabolic Syndromeunresolved

Interventions

INV-202DRUG

PlaceboDRUG

Sponsors & collaborators

Inversago Pharma Inc.lead sponsor

Mapped research locations

QuébecQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05282446 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.